News | August 03, 2021
Evexia Lifecare to manufacture API of Isometa
Robust demand for the product across the Middle East, Africa and Latin America
Robust demand for the product across the Middle East, Africa and Latin America
The company posted net profit of Rs.19.36 crores for the period ended June 30, 2020.
The govt has rolled out three schemes for promoting the manufacture of API
Drug formulations and biologics make impressive gains
Turnover of API division of ISLL stood at Rs 856.58 crore
The company posted net profit of Rs.111.44 crores for the period ended June 30, 2020.
The company posted net profit of Rs.19.36 crores for the period ended June 30, 2020.
The first six batches are being shipped to the Gamaleya Center, Moscow for the quality approval
The company has decided to transfer our rights in relation to the lodex and Ostocalcium brands to GlaxoSmithKline Asia Private Limited
Winlevi has been approved by the United States FDA as a novel drug with a unique mechanism of action for the topical treatment of acne in patients 12 years and older
Subscribe To Our Newsletter & Stay Updated
